华纳药厂：拟购买5个制剂项目的技术、出售4个制剂项目的技术

Group 1 - Warner Pharmaceuticals announced the acquisition of technology for 5 formulation projects from Zhuhai Qianlie Pharmaceutical Co., Ltd. for RMB 10.1 million and the transfer of technology for 4 formulation projects for RMB 7 million [1] - The transaction is classified as a related party transaction and does not constitute a major asset reorganization, having been approved by the company's board without the need for shareholder approval [1] - As of the report date, Warner Pharmaceuticals has a market capitalization of RMB 6.3 billion [1] Group 2 - For the fiscal year 2024, Warner Pharmaceuticals' revenue composition is 99.01% from pharmaceutical manufacturing and 0.99% from other businesses [1]